Rapid fibrinogen test during aortic dissection surgery
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a new device that quickly measures fibrinogen (a protein that helps blood clot) from a small blood sample during surgery for type A aortic dissection. It aims to help doctors make faster decisions about blood clotting treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having surgery for a type A aortic dissection (a tear in the main artery from the heart).
- You will need a routine TEG test (a blood clotting check) during surgery.
- You will receive fibrinogen concentrate (a medicine to help blood clot) during surgery.
- You do not need a heart-lung machine (ECMO) after surgery.
- You (or your family) can sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called INTERCEPT Fibrinogen Complex (IFC) to help control bleeding in trauma patients. It is given to patients who arrive at the hospital quickly after injury and have low fibrinogen levels.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
This trial tests a personalized dose of fibrinogen, a protein that helps blood clot, for people having heart surgery with a heart-lung machine. The goal is to see if a tailored dose works better than a fixed dose after surgery.
This trial tests whether using your own platelet-rich plasma during open surgery for type A aortic dissection can improve outcomes. If you qualify, you may receive this treatment to help with recovery.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
Hear when a new Hypofibrinogenemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.